A practical guide to managing hypertension, hyperlipidemia, and hyperglycemia in patients with chronic myeloid leukemia

Tyrosine kinase inhibitors (TKIs) have significantly improved the prognosis of chronic myeloid leukemia (CML) since their approval. Although safe in general, TKIs carry concerns about cardiovascular adverse events. Hypertension, diabetes, and dyslipidemia are among the most common baseline comorbidi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Khalid, Kaddoura, Rasha, Yassin, Mohamed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774492/
https://www.ncbi.nlm.nih.gov/pubmed/36569145
http://dx.doi.org/10.3389/fmed.2022.1025392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774492/
https://www.ncbi.nlm.nih.gov/pubmed/36569145
http://dx.doi.org/10.3389/fmed.2022.1025392

Ejemplares similares